Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Bacteriology|May 1, 1990
Functional analysis of pAL5000, a plasmid from Mycobacterium fortuitum: construction of a "mini" mycobacterium-Escherichia coli shuttle vectorM G Ranes, J Rauzier, M Lagranderie, et al.
AIDS Research and Human Retroviruses|December 31, 1998
A cocktail of Mycobacterium bovis BCG recombinants expressing the SIV Nef, Env, and Gag antigens induces antibody and cytotoxic responses in mice vaccinated by different mucosal routesM Lagranderie, N Winter, A M Balazuc, et al.
Infection and Immunity|September 19, 2000
Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routesM Abolhassani, M Lagranderie, P Chavarot, et al.
Vaccine|April 1, 1995
Recombinant BCG strains expressing the SIVmac251nef gene induce proliferative and CTL responses against nef synthetic peptides in miceN Winter, M Lagranderie, S Gangloff, et al.
Clinical and Experimental Immunology|January 1, 1985
Resistance of high and low antibody responder lines of mice to the growth of avirulent (BCG) and virulent (H37Rv) strains of mycobacteriaM Gheorghiu, D Mouton, H Lecoeur, et al.
Infection and Immunity|August 1, 1997
Genetic control of antibody responses induced by recombinant Mycobacterium bovis BCG expressing a foreign antigenM Lagranderie, R Lo-Man, E Dériaud, et al.
Microbiology (Reading, England)|November 1, 1996
Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovisW J Philipp, S Nair, G Guglielmi, et al.
AIDS Research and Human Retroviruses|January 16, 1998
Recombinant Mycobacterium bovis BCG producing the N-terminal half of SIVmac251 Env antigen induces neutralizing antibodies and cytotoxic T lymphocyte responses in mice and guinea pigsE M Lim, M Lagranderie, R Le Grand, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1993
BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory routeM Lagranderie, P Ravisse, G Marchal, et al.
Microbes and Infection|July 5, 2005
In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liverA M Balazuc, M Lagranderie, P Chavarot, et al.
Pageof 3